CBD Life Sciences (CBDL) Stock Price, News & Analysis

Company Overview

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Key Stats

• Today's Range: $0.0004 to $0.0004
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.02
• Volume: 8.58 million shs
• Average Volume: 18.31 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CBDL Stock Analysis - Frequently Asked Questions

How have CBDL shares performed this year?

CBD Life Sciences' stock was trading at $0.0005 at the start of the year. Since then, CBDL stock has decreased by 20.0% and is now trading at $0.0004.
View the best growth stocks for 2025 here.

How do I buy shares of CBD Life Sciences?

Shares of CBDL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CBD Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CBD Life Sciences investors own include 3D Systems (DDD), Baidu (BIDU), Silver Bull Resources (SVBL), Workday (WDAY), Zoom Video Communications (ZM), Clean Energy Fuels (CLNE) and ContextLogic (WISH).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CBDL
• CIK: 1776073
• Web: www.optiumcyber.com
• Phone: (480) 410-6780
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A